CCNB1 and cancer: Both Cox and Kaplan–Meier survival analyses indicated that higher CCNB1 expression correlates significantly with poorer OS in patients across 11 cancer types, namely, LGG, MESO, ACC, LIHC, LUAD, PAAD, BLCA, SKMC, KIRP, THYM, and KICH.